KRAS and neoplasm: Next, to further study the inhibitory effect of ITF2357 on the in vivo growth of Pem-resistant mut-KRAS NSCLC, A549R cells were injected subcutaneously into mice to establish tumor-bearing mice model, and ITF2357 alone or Pem in combination were given to monitor tumor growth.